Holen Sie sich die Stockscreener-App
75.44
1.90%
-1.46
Schlusskurs vom Vortag:
$76.90
Offen:
$76.26
24-Stunden-Volumen:
1.27M
Relative Volume:
2.16
Marktkapitalisierung:
$3.79B
Einnahmen:
$1.36B
Nettoeinkommen (Verlust:
$123.81M
KGV:
30.30
EPS:
2.49
Netto-Cashflow:
$20.35M
1W Leistung:
-7.08%
1M Leistung:
-11.16%
6M Leistung:
-11.77%
1J Leistung:
-12.47%
1-Tages-Spanne:
$74.70
$77.79
1-Wochen-Bereich:
$74.70
$83.32
52-Wochen-Spanne:
$70.25
$97.97
Haemonetics Corp Stock (HAE) Company Profile
Firmenname
Haemonetics Corp
Sektor
Telefon
(781) 848-7100
Adresse
125 SUMMER STREET, BOSTON, MA
Vergleichen Sie HAE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HAE
Haemonetics Corp
|
75.44 | 3.79B | 1.36B | 123.81M | 20.35M | 2.41 |
|
ISRG
Intuitive Surgical Inc
|
524.43 | 186.79B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
227.68 | 65.83B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
84.76 | 41.92B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
237.27 | 34.83B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
331.40 | 24.00B | 2.88B | 499.60M | 321.60M | 6.74 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-06 | Eingeleitet | JP Morgan | Overweight |
| 2024-11-08 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-09-13 | Eingeleitet | CL King | Buy |
| 2024-09-11 | Eingeleitet | BofA Securities | Neutral |
| 2024-09-10 | Eingeleitet | BTIG Research | Buy |
| 2024-06-12 | Hochstufung | Needham | Hold → Buy |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-01-27 | Herabstufung | Needham | Buy → Hold |
| 2021-12-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-08-17 | Fortgesetzt | Raymond James | Outperform |
| 2021-06-17 | Eingeleitet | Citigroup | Buy |
| 2021-05-14 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2021-04-20 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-19 | Herabstufung | CJS Securities | Market Outperform → Market Perform |
| 2021-02-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-01-21 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-11-05 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-03-31 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2020-01-10 | Eingeleitet | Needham | Buy |
| 2019-08-07 | Bestätigt | Barrington Research | Outperform |
| 2019-05-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-05-08 | Bestätigt | Barrington Research | Outperform |
| 2018-08-09 | Bestätigt | Barrington Research | Outperform |
| 2018-02-07 | Bestätigt | Barrington Research | Outperform |
| 2018-01-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2017-11-08 | Bestätigt | Barrington Research | Outperform |
| 2017-08-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2017-07-13 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2017-02-07 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-11-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2016-11-07 | Bestätigt | The Benchmark Company | Hold |
| 2016-09-20 | Herabstufung | CJS Securities | Market Outperform → Market Perform |
| 2016-08-15 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-08-02 | Bestätigt | Jefferies | Buy |
| 2016-08-02 | Bestätigt | The Benchmark Company | Hold |
Alle ansehen
Haemonetics Corp Aktie (HAE) Neueste Nachrichten
Haemonetics Co. (NYSE:HAE) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Investors three-year returns in Haemonetics (NYSE:HAE) have not grown faster than the company's underlying earnings growth - Yahoo Finance
Haemonetics Co. (NYSE:HAE) Position Lifted by Geode Capital Management LLC - MarketBeat
Zacks Research Predicts Haemonetics’ Q4 Earnings (NYSE:HAE) - Defense World
Zacks Research Forecasts Haemonetics' Q4 Earnings (NYSE:HAE) - MarketBeat
Zacks Research Forecasts Higher Earnings for Haemonetics - MarketBeat
Platelet Aggregation Devices Market Overall Study Report - openPR
BNP Paribas Financial Markets Has $1.36 Million Holdings in Haemonetics Co. (NYSE:HAE) - MarketBeat
Fmr LLC Has $62.26 Million Stake in Haemonetics Co. (NYSE:HAE) - MarketBeat
The Manufacturers Life Insurance Company Sells 248,835 Shares of Haemonetics Co. (NYSE:HAE) - MarketBeat
JPMorgan sets Haemonetics stock overweight with $116 target By Investing.com - Investing.com Nigeria
Settlement checks in the mail from Vizio, Haemonetics - Top Class Actions
Are Investors Undervaluing Haemonetics (HAE) Right Now? - Yahoo Finance
JPMorgan sets Haemonetics stock overweight with $116 target - Investing.com India
Haemonetics (NYSE:HAE) Now Covered by Analysts at JPMorgan Chase & Co. - MarketBeat
JP Morgan Initiates Coverage of Haemonetics (HAE) with Overweight Recommendation - MSN
Haemonetics (HAE) Shares Cross Below 200 DMA - Nasdaq
Zacks Industry Outlook Highlights ResMed, Haemonetics, Phibro and Agios - Yahoo Finance
Holocene Advisors LP Takes $5.42 Million Position in Haemonetics Co. (NYSE:HAE) - MarketBeat
The Latest Analyst Ratings For Haemonetics - Inkl
Wall Street Analysts See a 27.84% Upside in Haemonetics (HAE): Can the Stock Really Move This High? - Yahoo Finance
Will HAE Stock Gain Following Sell-Off of Whole Blood Assets to GVS? - Yahoo Finance
7,746 Shares in Haemonetics Co. (NYSE:HAE) Purchased by Paloma Partners Management Co - MarketBeat
Haemonetics to offload whole-blood business for up to $67M - Yahoo Finance
Haemonetics stock still a Buy as Whole Blood sale aligns with margin improvement efforts - Investing.com
Atom Investors LP Takes $1.57 Million Position in Haemonetics Co. (NYSE:HAE) - MarketBeat
Bridgewater Associates LP Has $629,000 Stock Holdings in Haemonetics Co. (NYSE:HAE) - MarketBeat
Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A - Quantisnow
Q3 EPS Estimates for Haemonetics Lowered by Zacks Research - MarketBeat
Zacks Research Decreases Earnings Estimates for Haemonetics - Defense World
Isthmus Partners LLC Decreases Stock Holdings in Haemonetics Co. (NYSE:HAE) - MarketBeat
Citigroup Inc. Sells 5,678,717 Shares of Haemonetics Co. (NYSE:HAE) - MarketBeat
Haemonetics Co. (NYSE:HAE) Shares Purchased by Loomis Sayles & Co. L P - MarketBeat
Intech Investment Management LLC Boosts Stake in Haemonetics Co. (NYSE:HAE) - MarketBeat
Haemonetics Co. (NYSE:HAE) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Eagle Asset Management Inc. Sells 118,636 Shares of Haemonetics Co. (NYSE:HAE) - MarketBeat
Westfield Capital Management Co. LP Has $66.21 Million Position in Haemonetics Co. (NYSE:HAE) - MarketBeat
Haemonetics Co. (NYSE:HAE) Shares Acquired by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
Leukapheresis Market 2024 Opportunity, Challenge, Drivers, - openPR
[Latest] Global Apheresis Equipment Market Size/Share Worth USD 13,169.1 Million by 2033 at a 12.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - GlobeNewswire Inc.
Global Alpha Capital Management Ltd. Invests $806,000 in Haemonetics Co. (NYSE:HAE) - MarketBeat
Haemonetics Co. (NYSE:HAE) Holdings Increased by Thrivent Financial for Lutherans - MarketBeat
Principal Financial Group Inc. Reduces Stock Holdings in Haemonetics Co. (NYSE:HAE) - MarketBeat
Haemonetics (NYSE:HAE) Given Buy Rating at Needham & Company LLC - MarketBeat
Royce & Associates LP Has $97.30 Million Position in Haemonetics Co. (NYSE:HAE) - MarketBeat
Aigen Investment Management LP Makes New Investment in Haemonetics Co. (NYSE:HAE) - MarketBeat
T. Rowe Price Investment Management, Inc. Expands Stake in Haemo - GuruFocus.com
Capital Research Global Investors Adjusts Stake in Haemonetics C - GuruFocus.com
Here's Why Haemonetics (HAE) is a Strong Value Stock - Yahoo Finance
Wall Street Analysts Think Haemonetics (HAE) Could Surge 25.58%: Read This Before Placing a Bet - Yahoo Finance
Haemonetics Corporation (NYSE:HAE) Q2 2025 Earnings Call Transcript - Insider Monkey
Finanzdaten der Haemonetics Corp-Aktie (HAE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
1.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):